N
Google TrendARSENAL (5000+) — Arsenal v Lille: Champions League – live
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:arsenal5000+anthony gordon500+montez sweat2000+rob lowe1000+tanner hudson500+frozen frenzy200+huevo1000+payton pritchard1000+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "GLP-1 Receptor Agonists R" (30 stories)

Top Headline Story

Genetic predictors of GLP1 receptor agonist weight loss and side effects
Lead StoryNaturegeneral
Apr 8

Genetic predictors of GLP1 receptor agonist weight loss and side effects

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9IUFh1U2pjNEx4RVVDZmxGRWQ4NTZRS2NoVGFGa2NqeWNWZmJZd3NQOXAyMk84NlY2aTh6d0d6Y1F6V1d5a1RibFRMYlpNNER2R3BqMTNYNGJXSHozZ0w0?oc=5" target="_blank">Genetic predictors of GLP1 receptor agonist weight loss and side effects</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
5000+19m ago

arsenal

Arsenal v Lille: Champions League – live

Filter stories
500+19m ago

anthony gordon

Anthony Gordon's first Barcelona goal, Manuel Neuer's mistake and Djed Spence's Inter debut in the Euro Debrief

Filter stories
2000+29m ago

montez sweat

Bears DE Montez Sweat suspended two games for violating NFL's PED policy

Filter stories
1000+39m ago

rob lowe

Ben Shapiro’s Star-Studded ‘Confession’ Film Includes James Franco, Rob Lowe And More

Filter stories

Search Results for "GLP-1 Receptor Agonists R"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
GLP-1 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits
The Lancetgeneral

GLP-1 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxNUktFelBLS0Etd1RrSkhxT0hZZmUzS0RkdVNSQXFhYThzNUE4TGdKU245QmhxZVlfX1FkYWRfRU9WcVpWSUFrdmlYWnhrbTB3NW1KdVRSLVUwVVg3SktkeEhrRk8xWGRLTWY4SWowekN4M0RwdnBtRTlVdE5QU0pXUGs4Vk5zUk9yd3Nz?oc=5" target="_blank">GLP-1 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits</a>  <font color="#6f6f6f">The Lancet</font>

Read Full StoryMore like this
GLP-1 Receptor Agonists as Potential Treatments for Alcohol Use Disorder
Psychiatry Onlinegeneral

GLP-1 Receptor Agonists as Potential Treatments for Alcohol Use Disorder

<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFBWWUxXVUxwVldSOEY3Ymt2eXhiTHJGSTBDSk5ETXhSd0RVbURxQm9SS1FyeXduc2ZqbXExdm9TMFFKa0lKUnBVcTFKQ2hGN19lOFV1MnFDYXhXTG1Gb3FucjRYamc1cUVxc0E?oc=5" target="_blank">GLP-1 Receptor Agonists as Potential Treatments for Alcohol Use Disorder</a>  <font color="#6f6f6f">Psychiatry Online</font>

Read Full StoryMore like this
The mechanisms of GLP-1 receptor agonists in liver diseases: their multifaceted impact on immune response and metabolic regulation
Frontiersworld

The mechanisms of GLP-1 receptor agonists in liver diseases: their multifaceted impact on immune response and metabolic regulation

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxOd0xLVFFFdmZpenBOd0VwaktxUDBKNkJ3cEE2YzdHYl9lclM4aEhfQ001Q0lMSGlyQmlWNFBWZG1nLU1IT0hRaGx4NjIwRW9qdFJTNWZCXy03UlB6SDZXdXo1aTV2U1phdzlvRXZWSE9jN29nSmc5T2pHbEk0NktyNTFIR2haTlhaRVpaRk1tN0djTDZF?oc=5" target="_blank">The mechanisms of GLP-1 receptor agonists in liver diseases: their multifaceted impact on immune response and metabolic regulation</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
SGLT2 vs GLP-1: Individualizing Diabetes, Cardiovascular, and Renal Outcomes
Renal and Urology Newsgeneral

SGLT2 vs GLP-1: Individualizing Diabetes, Cardiovascular, and Renal Outcomes

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxQN3dHZ3d1YlEyN2ZjSGYzc1ozaGt5eE5JMXpiQlhoOWtjN2RJR1plN3BPRzZ5QnBBNGp0REgzQmREUy1MajBlTVVpWEdlRzUxbjZjME9BX1kydkNaZVVNS3BqMG83ckEtdGkzbEhCdzQwZW1WWkZjLWRyWjg2MWptWVIzSTdwSGVmTnRiN2tuUGdodGN2ek8za19zaFFpUk1BVk1OQXhzaDVqblZiaG5Ec2o0R280QUZCNy1n?oc=5" target="_blank">SGLT2 vs GLP-1: Individualizing Diabetes, Cardiovascular, and Renal Outcomes</a>  <font color="#6f6f6f">Renal and Urology News</font>

Read Full StoryMore like this
GLP-1 Receptor Agonists and Research to Treat Overeating and Substance Use Disorders
Journal of Neurosciencegeneral

GLP-1 Receptor Agonists and Research to Treat Overeating and Substance Use Disorders

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE1YSlJMb0Nlc282N3RwMWZaSExFU0Y5WWtBOVBCSkNuajZzazJZQktQR1NaTDRVV3ZTaFJ0UXJSSV9pamFVRUFGb21jVWxGaXhiQlg0bEQ4Q3pxSHNGQkZJZg?oc=5" target="_blank">GLP-1 Receptor Agonists and Research to Treat Overeating and Substance Use Disorders</a>  <font color="#6f6f6f">Journal of Neuroscience</font>

Read Full StoryMore like this
GLP-1 Receptor Agonists : New England Journal of Medicine
Ovidgeneral

GLP-1 Receptor Agonists : New England Journal of Medicine

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxQbTBFRVp0aUtwaGY2U1FpRDBzWU1nN0dMTkdFdDhlMnJHamJWNXRSQmxrTktkYWU0d3ZhREJobkNzQ1VjMFZYRXg4bkdVZmcyYkYxVlBQYWRPdHFxeGhMSkFJVzNtTXNueHlUUGdFcVFEdnpvc2sxU3JWNDVIV2FfdVdYd25vcmtYcUVPdWdzZzZkLVk?oc=5" target="_blank">GLP-1 Receptor Agonists : New England Journal of Medicine</a>  <font color="#6f6f6f">Ovid</font>

Read Full StoryMore like this
The Benefits and Risks of Glucagon-Like Peptide-1 Receptor Agonists on Ocular Diseases: A Narrative Review
Cureusgeneral

The Benefits and Risks of Glucagon-Like Peptide-1 Receptor Agonists on Ocular Diseases: A Narrative Review

<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxQQ1pqYVowR1JhTmFTNGk2N1JJSEdkX2EyLUlpLWJ2UlB0U0RYdEFENTBEbndCdU1PWW1oUXB3OGJWdFh2dnlzelJ1dTQ4aXpzdFJxdld5WEdHVGIwSDVHU3lya3RDUXo1MXhUZVUyZm4yVS1rUFJMZjBzV0ljNlJPaF9yNTl0MUxhX25PMjVhN1ByZmZKd2dFN3dhckh6UmdHZjR5d1hKbU1yZVdpZkNzNDkxekxrcFI5b2pGbUNvUUozdkVvaWdWdG1YNklUZ0tMQXB5YTBLal9GOURN?oc=5" target="_blank">The Benefits and Risks of Glucagon-Like Peptide-1 Receptor Agonists on Ocular Diseases: A Narrative Review</a>  <font color="#6f6f6f">Cureus</font>

Read Full StoryMore like this
Suicidality as a potential risk and therapeutic target during widespread GLP-1 receptor agonists use: implications of inflammation
Frontiersgeneral

Suicidality as a potential risk and therapeutic target during widespread GLP-1 receptor agonists use: implications of inflammation

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQMHM1N3VvRnZfRG9rSjlGZkh5TnhXVldYS1g1TzRHYU5PTVJHYUllUEF3NkNBaEo0S3N2aWgyN1lYTl9HSEVvemtnNkp5X3pzbXZhU1pyRUN5VG8xRHJ2X2Q0Q2UwS1V5M3Y1LWk5X2JvSTdqNFRDTFpwelNDUy1sNzlTYW5nd3VmbW84Slg2bW1UMHNSblo3ZTM4ckxLZFlO?oc=5" target="_blank">Suicidality as a potential risk and therapeutic target during widespread GLP-1 receptor agonists use: implications of inflammation</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
weight loss drug that starts with an r
polskieradio.plgeneral

weight loss drug that starts with an r

<a href="https://news.google.com/rss/articles/CBMie0FVX3lxTE9JLW1fZlZWcmR3eXh6bm9Zbjc4SlR5aUVuV2ItMUMxcTB0SnM5MEs2d0hvUmJtNUQ5WkdYSm9lVTR0Z0VhMDZEOE1mSnRMUmtPdGZmaHJxMEFCYnFNR0FsM1B0TGE1UTFZQ3FaYkZuMVVYU1pZSFk4X0luTQ?oc=5" target="_blank">weight loss drug that starts with an r</a>  <font color="#6f6f6f">polskieradio.pl</font>

Read Full StoryMore like this
Integrative gene-metabolite network analysis of GLP-1 receptor agonists and related incretin pathways in cardiometabolic health
Naturescience

Integrative gene-metabolite network analysis of GLP-1 receptor agonists and related incretin pathways in cardiometabolic health

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9iY05ZSGdrem5PYlhIckQwcC05dFRJd25kMG0zU1N5dUFIc2hwX1FMaU12elJ5c242Nm1MVGNaYVBMSGdYM0pCMkdzX3RkMlp1cTRnN25xYWtaR3lGbmtz?oc=5" target="_blank">Integrative gene-metabolite network analysis of GLP-1 receptor agonists and related incretin pathways in cardiometabolic health</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
GLP-1 Receptor Agonists as Potential Treatments for Alcohol Use Disorder
Psychiatry Onlinegeneral

GLP-1 Receptor Agonists as Potential Treatments for Alcohol Use Disorder

<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTE4tak1BWTZYdGxDbzlhbUVXcTFGUy1TSHpJNDRkUlNoc3piWG1XWHBNN2NtY0piQXFOS2M4Z08xaEV2b2pVc21EZkRITXM0Y3BLcllGdW04VW5NX2pQRV9zYmtpR1VHcERiY0xMZS1pakZzclFV?oc=5" target="_blank">GLP-1 Receptor Agonists as Potential Treatments for Alcohol Use Disorder</a>  <font color="#6f6f6f">Psychiatry Online</font>

Read Full StoryMore like this
GLP-1 Receptor Agonists: From Clinical Success to Mechanistic Insight
American Heart Association Journalsgeneral

GLP-1 Receptor Agonists: From Clinical Success to Mechanistic Insight

<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE5Rc01pVlRqejhSUFVQVzN0TUZScElhMF9yNG5KQ1p2emU2aXBjTmc2LVE5aUVIOEt5TEVHZkpWallYLVhUVHI3MXRxMmF4elduTlRMOHY4Z0RvZWFCYW9lNzRES3IwTEhIeGM2aHpn?oc=5" target="_blank">GLP-1 Receptor Agonists: From Clinical Success to Mechanistic Insight</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Read Full StoryMore like this
Designing GLP-1 delivery: structural perspectives and formulation approaches for optimized therapy
Naturegeneral

Designing GLP-1 delivery: structural perspectives and formulation approaches for optimized therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1TRFhqOTg4eVhaYVdnejkwTVpaRkl1QTJjd0dRMHN3R29ST2dzdkdjNG9BdU1xdDRPMXotc1l5QW03RHVaVE0takhCQmJEMnJfem1pcnlVSWR3S0Z1TjI0?oc=5" target="_blank">Designing GLP-1 delivery: structural perspectives and formulation approaches for optimized therapy</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
GLP-1 agonists and exercise: the future of lifestyle prioritization
Frontiersgeneral

GLP-1 agonists and exercise: the future of lifestyle prioritization

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxNTjZDeHd4UW5acHI0WU1XT2ZOeXdaN1dyNHhmaFJhT251RzVIdXZyOW9pUUhLN19UTkczS2c1V2FqYlF0MW9ra3JULWNSa3JZNWJXclNpUXFBRkkzMVBOT0hGam9ndEhEQ3VHU0x4SXNsTGpCUmh0dWpSN2txcnpvVGpxNEMyOVVJeU0xV2IwZW9aLUY1bFQwMnkwMDVvMFpheUY0MTlQYXhFZkphXy1B?oc=5" target="_blank">GLP-1 agonists and exercise: the future of lifestyle prioritization</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
GLP-1 Receptor Agonists and Research to Treat Overeating and Substance Use Disorders
Journal of Neurosciencegeneral

GLP-1 Receptor Agonists and Research to Treat Overeating and Substance Use Disorders

<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE1PbWJ0ZmVLc1FFTTdVRTd3dWE1MHpELUVuT3hwMktxbEJMcUw1RXY3bEJZVHVtaGFROVJySTZjaF9FZ3J2ZWJUYjNaSVVvQlRKb3BmOGUybDZBdFU4LXVGaWxFV3ZWaEktTnpEWm9GNTB2MW5Md2ow?oc=5" target="_blank">GLP-1 Receptor Agonists and Research to Treat Overeating and Substance Use Disorders</a>  <font color="#6f6f6f">Journal of Neuroscience</font>

Read Full StoryMore like this
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy | Signal Transduction and Targeted Therapy
Naturegeneral

Glucagon-like peptide-1 receptor: mechanisms and advances in therapy | Signal Transduction and Targeted Therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBrblBnd2pwWm5YN2RsN2h1ZkkwU3d1b25oT1NwY3k1ajBsVGxkNlZyWmwwTC02NFVlNzQyR013N29EaTBMUjRRWW54aHpjdUVwbFNuQ0RheVdXaEhJbEdn?oc=5" target="_blank">Glucagon-like peptide-1 receptor: mechanisms and advances in therapy | Signal Transduction and Targeted Therapy</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
GLP-1 receptor agonists: exploration of transformation from metabolic regulation to multi-organ therapy
Frontiersgeneral

GLP-1 receptor agonists: exploration of transformation from metabolic regulation to multi-organ therapy

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxPd2xpQ184SWl4LVZ4eWRFSkF4YWNOSUFodGMtS203MWlBOXBhNENmc3JZYVFwa3VmOGNGRVJvUXJONXN6a0tpNzJDTFFLS3hfRWFiZG1ocmtEVkNWZllTbkQ5SUM0X1Q3ZWpsa2RKNkpyOXVtRk1PNnRadzBGWGZveU9VMy14OFlEaW9QcWo1ckhNSEVJ?oc=5" target="_blank">GLP-1 receptor agonists: exploration of transformation from metabolic regulation to multi-organ therapy</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists
Frontiersgeneral

Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxQN2thYnQ5RXZ2dDhfLXFUU2FCVjRvNEFSeE1RVDg5ckVmNkVWejNCSDJ6ekhVUFFDMTI3Q2xnaHU2c3h1NTQwY1RyX2RGZHRUVDdWTTJSQjdWTl93ZDRIME5HdWJzUFRSRW5fRDlseVh1cFhvRE1TUWlFX0tMZ2tSS0VWNnlnWGdOaVdoWE81UC1ZSEdVMkE?oc=5" target="_blank">Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Disproportionality analysis of GLP-1 receptor agonists combined with metformin based on the FAERS database
Naturegeneral

Disproportionality analysis of GLP-1 receptor agonists combined with metformin based on the FAERS database

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5IX0RVanlRczZSTDlQb2xUeUZyc25GeGV4Ul9wd2tjTjM4NnplQjlHMlNxRW5McVBISHdnanZZbC1yWW5CaDJoN3FCMTRoaGQ1M2YxQllveVRJbkJvTms4?oc=5" target="_blank">Disproportionality analysis of GLP-1 receptor agonists combined with metformin based on the FAERS database</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach
Frontiersgeneral

GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxNbFF3QWVNZU1iamV2RDhEeXRIeXdibnU0dVo4Sjc2UVBNOGpYRndxVnlGWW1rM1V2VU1LMmhyNmJ1dkhWb1BVamJONmVmYWVHQk9ZX2FiUTRtVG5sanVBeXhiUGJNcHpQRGdPNFc2VF9yR0tRX1NQUElrb21IWmFhZlVPV2EzRkhEVTQzQTk2V21Lb3RpY1E?oc=5" target="_blank">GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Risk of pancreatic cancer associated with GLP-1 receptor agonist therapy
Naturegeneral

Risk of pancreatic cancer associated with GLP-1 receptor agonist therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE90Tm0xMXVTMGUtN2xNbzJyUXF0dkZiYjA0Ql9vSndkVmp1a09nM3F4T3lJRFU1RHBhb3ZGal9Ca1Y1NGRSUUVBQ1ZPYzFaUFI1R2hFZEtiZmlza01EZDNJ?oc=5" target="_blank">Risk of pancreatic cancer associated with GLP-1 receptor agonist therapy</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
AI‐Driven De Novo Design of Ultra Long‐Acting GLP‐1 Receptor Agonists
Wiley & Sonstech

AI‐Driven De Novo Design of Ultra Long‐Acting GLP‐1 Receptor Agonists

<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE5iZjJ0ZjVvdkMyeGExX0EwcmhBdWNvX3Ita191akJRU2U3YkRIVFJuTHdOejE0LVE0d1p4N09pNnY3bkYwa056akgzRW1GNFBXWU5MTGpCcXJJSnhQRFhBNC1IQUZZSDJpcHFZZGE0WG1UclZ2RWc?oc=5" target="_blank">AI‐Driven De Novo Design of Ultra Long‐Acting GLP‐1 Receptor Agonists</a>  <font color="#6f6f6f">Wiley & Sons</font>

Read Full StoryMore like this
Gastrointestinal adverse events associated with GLP-1 RA in non-diabetic patients with overweight or obesity: a systematic review and network meta-analysis | International Journal of Obesity
Naturegeneral

Gastrointestinal adverse events associated with GLP-1 RA in non-diabetic patients with overweight or obesity: a systematic review and network meta-analysis | International Journal of Obesity

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1hZm1qcHJHeEdNMlM2V1ZPOXRFQXRqZUhQT2xTT2ZtRkdlZFRzUkdhaHhXN1hCckNBRnJ2WEZhMVJ5SlBCdFVDaW5zbUc0RF9NajJZUzZJREt1WTZkak9Z?oc=5" target="_blank">Gastrointestinal adverse events associated with GLP-1 RA in non-diabetic patients with overweight or obesity: a systematic review and network meta-analysis | International Journal of Obesity</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
A System-Based Review on Effects of Glucagon-Like Peptide-1 Receptor Agonists: Benefits vs Risks
Cureusgeneral

A System-Based Review on Effects of Glucagon-Like Peptide-1 Receptor Agonists: Benefits vs Risks

<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxNN0lkWkwxT21zUkQ3RVZvTkdEYUQ4V1Q4b0xaZkcweF9GdVdYaVg5NmhtbkRVZE5ZaXVESmRNSkdkX3hyY05GX3p1R1pzQm5HR01abEZpNzVLbHBCQ09lcUJZQVRfbVd6Z21sRlRmVHRnUEVVcW53T055MlJWXzNBRnhtQ3JOeU1DZU1JLV9VVkZvY3dPZ1FURm1BTEpMcVN6ZDV3WDRlcjFCb19BWTRtT2xCazBQdGp6NnZDN0pqSWlxR3B5NEhkZjgxVlVReHM?oc=5" target="_blank">A System-Based Review on Effects of Glucagon-Like Peptide-1 Receptor Agonists: Benefits vs Risks</a>  <font color="#6f6f6f">Cureus</font>

Read Full StoryMore like this
Five Unexpected New Uses for GLP-1 Receptor Agonists
Pharmacy Timesworld

Five Unexpected New Uses for GLP-1 Receptor Agonists

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxOREtjOVEtcWdTV19WSU1OTHI0NXlIV3k2MGs5bU1qRGxmTFpjeGdRbjhWcEs4Y21uOTBTOHo0aUZUc0xnQ2FQa0lCaV8tcEdIT2lETkx0OU90d2Y2TnZSMVcxVkp6bXRKcVE2MHhzdy1NT3F1WkZCRmVfdm5mQmh3TjBXeWtjZEIyaTdQRnFObjE?oc=5" target="_blank">Five Unexpected New Uses for GLP-1 Receptor Agonists</a>  <font color="#6f6f6f">Pharmacy Times</font>

Read Full StoryMore like this
GLP-1-based medications: Mechanisms involved in obesity treatment
www.elsevier.comgeneral

GLP-1-based medications: Mechanisms involved in obesity treatment

<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxQaS1udkdnSGtCc2kzTmNINWw0N0dDSFIzRFFzMTdJZUVyYW1QbF94d1dZMmpZRWdDaW1iWDNNUVJXU2lLOTFYeGxHWFY0NU5Cd3BvWGpOWldVTmVXRmdlb2NNR2hmcE5zS0h5OFgwSlNxbzF5N1lycHdVWmUwN2NoRlY5WDlxY0FkZF94bnlHN0tzOEh6Z1dKSk1MZnZYSWtxa2s3TjVjTUJuWFJhLTdvb3Nqbjk0aVp0cjZLaV9Yalg2enRqSnFtNjhxOEhMd1E1YW9VVmFHbzFvcVdGVEFz?oc=5" target="_blank">GLP-1-based medications: Mechanisms involved in obesity treatment</a>  <font color="#6f6f6f">www.elsevier.com</font>

Read Full StoryMore like this
First-Time Prescribing of GLP-1 Receptor Agonists from 2018-2023: A Descriptive Analysis
medRxivgeneral

First-Time Prescribing of GLP-1 Receptor Agonists from 2018-2023: A Descriptive Analysis

<a href="https://news.google.com/rss/articles/CBMickFVX3lxTE9ydlloRDdndzJlRHFLc1RWNkpsV0FTQ3JMV3JsZHVNTE1iY3dQTjBmNGpNd3VTcXp1RFEydi0tUWx0VnJtUzdKUE5zSTJOd1NBSERLNmxySk5lU09BZWp6WS1UdU1Ib3F3N1JPV1hFang3QQ?oc=5" target="_blank">First-Time Prescribing of GLP-1 Receptor Agonists from 2018-2023: A Descriptive Analysis</a>  <font color="#6f6f6f">medRxiv</font>

Read Full StoryMore like this
GLP-1 Receptor Agonists: Trend, Necessity, or Blessing?
The American Journal of Managed Caregeneral

GLP-1 Receptor Agonists: Trend, Necessity, or Blessing?

<a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxQb3ZFZlhDbnhNMFpmUHRicDN6WVhpMGstS3pBUnFTQXBLdllHRkZiNV9VZDNsTjdCZ3BMRUE0WjFTME56cE9CSU9udlV6REQ4cUIxNU9uM1phVTItbFNrc3huamI2UHE5WE9mTVFHQUFHU0VwRWszVXlhLXRBTDVvbm8yVlY?oc=5" target="_blank">GLP-1 Receptor Agonists: Trend, Necessity, or Blessing?</a>  <font color="#6f6f6f">The American Journal of Managed Care</font>

Read Full StoryMore like this
Glucagon-like peptide-1 receptor agonists improve metabolic dysfunction-associated steatotic liver disease outcomes
Natureworld

Glucagon-like peptide-1 receptor agonists improve metabolic dysfunction-associated steatotic liver disease outcomes

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9zRno1eEthSk53SENaYmZ4VEJYNVljdGdURkhYUk5WY3RkQmNfWnpqM3RJbm5jeWRSenFfdWd0eUQyMVRpRjFLQnBiWU5uV1l1dFcwMTBxN3ROWUhxQTQ4?oc=5" target="_blank">Glucagon-like peptide-1 receptor agonists improve metabolic dysfunction-associated steatotic liver disease outcomes</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
"GLP-1 Receptor Agonists R" — Live Google News Trends & Headlines